Trizma® base
≥99.9% (titration), crystalline
Receive your quote directly from the manufacturer.
Available large-scale upon request. The products are part of Merck KGaA, Darmstadt, Germany's Elevated Assurance Program. This program instills confidence as you navigate this complex landscape. Merck KGaA, Darmstadt, Germany provides the necessary documentation to support your audits and risk assessments. Products in this program support your needs for supply chain transparency, as well as manufacturing and quality controls.
TechTalk: Buffer optimization for lateral flow assay development
Friday, June 19 at 16:00 BST | 17:00 CEST | 11:00 EDT | 08:00 PDT
Discover a practical approach to buffer selection and optimization for lateral flow assays (LFAs), with an emphasis on integrating buffer development early in the project.
In this 20-minute SelectScience® TechTalk we will cover antibody stability, non-specific binding, and kinetic considerations, as well as the impact of sample matrices and flow dynamics. We will also evaluate protein adsorption on membranes, detergent choice, and how optimized buffers for the sample and conjugate pads promote uniform flow and minimize nonspecific interactions.
The TechTalk will also cover production-scale buffer considerations and highlight Merck KGaA, Darmstadt, Germany’s LFA Development Services as a value-added resource. Attendees will gain actionable strategies to accelerate assay development, improve performance, and streamline scale-up.
This TechTalk is part seven of a seven-part expert-led TechTalk series on essential topics in LFA development. Register to watch live or on demand and receive exclusive invitations to upcoming sessions.
The Life Science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada.
TechTalk details
- Cost: Free to attend
- Location: Online
- Duration: 20 minutes
Registration is required to secure your place. If you register but can’t attend live, you will receive a link to the on‑demand recording once it becomes available.
